{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T18:59:07Z","timestamp":1791831547222,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T00:00:00Z","timestamp":1729728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100014718","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 32002353"],"award-info":[{"award-number":["No. 32002353"]}],"id":[{"id":"10.13039\/100014718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["No. 2022NSFSC1680"],"award-info":[{"award-number":["No. 2022NSFSC1680"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-024-03988-7","type":"journal-article","created":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T12:03:32Z","timestamp":1729771412000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Adipose-derived mesenchymal stem cells inhibit hepatic stellate cells activation to alleviate liver fibrosis via Hippo pathway"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7495-9332","authenticated-orcid":false,"given":"Haifeng","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haocheng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchuan","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinmiao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangneng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouchao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dechun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijun","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,24]]},"reference":[{"key":"3988_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5152\/tjg.2018.17330","volume":"29","author":"MM Ayd\u0131n","year":"2018","unstructured":"Ayd\u0131n MM, Ak\u00e7al\u0131 KC. Liver fibrosis. Turkish J Gastroenterology: Official J Turkish Soc Gastroenterol. 2018;29:14\u201321.","journal-title":"Turkish J Gastroenterology: Official J Turkish Soc Gastroenterol"},{"key":"3988_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1055\/s-0036-1597816","volume":"37","author":"L Campana","year":"2017","unstructured":"Campana L, Iredale JP. Regression of liver fibrosis. Semin Liver Dis. 2017;37:1\u201310.","journal-title":"Semin Liver Dis"},{"key":"3988_CR3","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s41232-022-00235-5","volume":"42","author":"M Pibiri","year":"2022","unstructured":"Pibiri M, Simbula G. Role of the Hippo pathway in liver regeneration and repair: recent advances. Inflamm Regeneration. 2022;42:59.","journal-title":"Inflamm Regeneration"},{"key":"3988_CR4","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.bbrc.2020.03.148","volume":"526","author":"K Yasuda","year":"2020","unstructured":"Yasuda K, Kotaka M, Toyohara T, Sueta SI, Katakai Y, Ageyama N, et al. A nonhuman primate model of liver fibrosis towards cell therapy for liver cirrhosis. Biochem Biophys Res Commun. 2020;526:661\u20139.","journal-title":"Biochem Biophys Res Commun"},{"key":"3988_CR5","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1146\/annurev-pathol-011110-130246","volume":"6","author":"V Hernandez-Gea","year":"2011","unstructured":"Hernandez-Gea V, Friedman SL. Pathogenesis of liver fibrosis. Annu Rev Pathol. 2011;6:425\u201356.","journal-title":"Annu Rev Pathol"},{"key":"3988_CR6","doi-asserted-by":"crossref","unstructured":"Yuan S, Wei C, Liu G, Zhang L, Li J, Li L et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1\u03b1\/SLC7A11 pathway. 2022;55:e13158.","DOI":"10.1111\/cpr.13158"},{"key":"3988_CR7","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","volume":"65","author":"M Parola","year":"2019","unstructured":"Parola M, Pinzani M. Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues. Mol Aspects Med. 2019;65:37\u201355.","journal-title":"Mol Aspects Med"},{"key":"3988_CR8","doi-asserted-by":"crossref","unstructured":"Roehlen N, Crouchet E, Baumert TF. Liver fibrosis: mechanistic concepts and therapeutic perspectives. Cells. 2020;9.","DOI":"10.3390\/cells9040875"},{"key":"3988_CR9","doi-asserted-by":"crossref","unstructured":"Dewidar B, Meyer C, Dooley S, Meindl-Beinker AN. TGF-\u03b2 in hepatic stellate cell activation and liver fibrogenesis-updated 2019. Cells. 2019;8.","DOI":"10.3390\/cells8111419"},{"key":"3988_CR10","doi-asserted-by":"publisher","first-page":"8618","DOI":"10.1002\/jcp.27846","volume":"234","author":"MB Gugjoo","year":"2019","unstructured":"Gugjoo MB, Amarpal, Fazili MR, Shah RA, Sharma GT. Mesenchymal stem cell: basic research and potential applications in cattle and buffalo. J Cell Physiol. 2019;234:8618\u201335.","journal-title":"J Cell Physiol"},{"key":"3988_CR11","doi-asserted-by":"crossref","unstructured":"Vasanthan J, Gurusamy N, Rajasingh S, Sigamani V, Kirankumar S, Thomas EL et al. Role of human mesenchymal stem cells in regenerative therapy. Cells. 2020;10.","DOI":"10.3390\/cells10010054"},{"key":"3988_CR12","first-page":"125","volume":"35","author":"S Al-Ghadban","year":"2020","unstructured":"Al-Ghadban S, Bunnell BA. Adipose tissue-derived stem cells: Immunomodulatory effects and therapeutic potential. Physiol (Bethesda Md). 2020;35:125\u201333.","journal-title":"Physiol (Bethesda Md)"},{"key":"3988_CR13","doi-asserted-by":"crossref","unstructured":"Bunnell BA. Adipose tissue-derived mesenchymal stem cells. Cells. 2021;10.","DOI":"10.3390\/cells10123433"},{"key":"3988_CR14","doi-asserted-by":"crossref","unstructured":"Khomich O, Ivanov AV, Bartosch B. Metabolic hallmarks of hepatic stellate cells in liver fibrosis. Cells. 2019;9.","DOI":"10.3390\/cells9010024"},{"key":"3988_CR15","doi-asserted-by":"crossref","unstructured":"Wei X, Ma W, Gu H, Liu D, Luo W, Cao S et al. Intra-amniotic mesenchymal stem cell therapy improves the amniotic fluid microenvironment in rat spina bifida aperta fetuses. 2023;56:e13354.","DOI":"10.1111\/cpr.13354"},{"key":"3988_CR16","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41423-023-00983-5","volume":"20","author":"X Yang","year":"2023","unstructured":"Yang X, Li Q, Liu W, Zong C, Wei L, Shi Y, et al. Mesenchymal stromal cells in hepatic fibrosis\/cirrhosis: from pathogenesis to treatment. Cell Mol Immunol. 2023;20:583\u201399.","journal-title":"Cell Mol Immunol"},{"key":"3988_CR17","doi-asserted-by":"publisher","first-page":"e654","DOI":"10.1002\/mco2.654","volume":"5","author":"L Chen","year":"2024","unstructured":"Chen L, Huang Y, Zhang N, Qu J, Fang Y, Fu J, et al. Single-cell RNA sequencing reveals reduced intercellular adhesion molecule crosstalk between activated hepatic stellate cells and neutrophils alleviating liver fibrosis in hepatitis B virus transgenic mice post menstrual blood-derived mesenchymal stem cell transplantation. MedComm. 2024;5:e654.","journal-title":"MedComm"},{"key":"3988_CR18","doi-asserted-by":"crossref","unstructured":"Chen P, Yuan M, Yao L, Xiong Z, Liu P, Wang Z, et al. Human umbilical cord-derived mesenchymal stem cells ameliorate liver fibrosis by improving mitochondrial function via Slc25a47-Sirt3 signaling pathway. Volume 171. Biomedicine & pharmacotherapy\u2009=\u2009Biomedecine & pharmacotherapie; 2024. p. 116133.","DOI":"10.1016\/j.biopha.2024.116133"},{"key":"3988_CR19","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s41232-017-0045-6","volume":"37","author":"A Tsuchiya","year":"2017","unstructured":"Tsuchiya A, Kojima Y, Ikarashi S, Seino S, Watanabe Y, Kawata Y, et al. Clinical trials using mesenchymal stem cells in liver diseases and inflammatory bowel diseases. Inflamm Regeneration. 2017;37:16.","journal-title":"Inflamm Regeneration"},{"key":"3988_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/s41392-022-01191-9","volume":"7","author":"M Fu","year":"2022","unstructured":"Fu M, Hu Y, Lan T, Guan KL, Luo T, Luo M. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Therapy. 2022;7:376.","journal-title":"Signal Transduct Target Therapy"},{"key":"3988_CR21","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.addr.2017.05.007","volume":"121","author":"T Higashi","year":"2017","unstructured":"Higashi T, Friedman SL, Hoshida Y. Hepatic stellate cells as key target in liver fibrosis. Adv Drug Deliv Rev. 2017;121:27\u201342.","journal-title":"Adv Drug Deliv Rev"},{"key":"3988_CR22","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1038\/s41401-021-00754-w","volume":"42","author":"ZN Lu","year":"2021","unstructured":"Lu ZN, Niu WX, Zhang N, Ge MX, Bao YY, Ren Y, et al. Pantoprazole ameliorates liver fibrosis and suppresses hepatic stellate cell activation in bile duct ligation rats by promoting YAP degradation. Acta Pharmacol Sin. 2021;42:1808\u201320.","journal-title":"Acta Pharmacol Sin"},{"key":"3988_CR23","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1016\/j.jhep.2021.11.031","volume":"76","author":"X Wang","year":"2022","unstructured":"Wang X, Zeldin S, Shi H, Zhu C, Saito Y, Corey KE, et al. TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis. J Hepatol. 2022;76:910\u201320.","journal-title":"J Hepatol"},{"key":"3988_CR24","doi-asserted-by":"publisher","first-page":"30029","DOI":"10.1038\/srep30029","volume":"6","author":"K Zhang","year":"2016","unstructured":"Zhang K, Chang Y, Shi Z, Han X, Han Y, Yao Q, et al. \u03c9-3 PUFAs ameliorate liver fibrosis and inhibit hepatic stellate cells proliferation and activation by promoting YAP\/TAZ degradation. Sci Rep. 2016;6:30029.","journal-title":"Sci Rep"},{"key":"3988_CR25","doi-asserted-by":"publisher","first-page":"e0213220","DOI":"10.1371\/journal.pone.0213220","volume":"14","author":"M Yoshida","year":"2019","unstructured":"Yoshida M, Horiguchi H, Kikuchi S, Iyama S, Ikeda H, Goto A, et al. miR-7977 inhibits the Hippo-YAP signaling pathway in bone marrow mesenchymal stromal cells. PLoS ONE. 2019;14:e0213220.","journal-title":"PLoS ONE"},{"key":"3988_CR26","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1136\/gutjnl-2014-306842","volume":"64","author":"YA Lee","year":"2015","unstructured":"Lee YA, Wallace MC, Friedman SL. Pathobiology of liver fibrosis: a translational success story. Gut. 2015;64:830\u201341.","journal-title":"Gut"},{"key":"3988_CR27","doi-asserted-by":"crossref","unstructured":"Baglieri J, Brenner DA, Kisseleva T. The role of Fibrosis and Liver-Associated fibroblasts in the pathogenesis of Hepatocellular Carcinoma. Int J Mol Sci. 2019;20.","DOI":"10.3390\/ijms20071723"},{"key":"3988_CR28","doi-asserted-by":"publisher","first-page":"306","DOI":"10.5009\/gnl18412","volume":"14","author":"SH Kang","year":"2020","unstructured":"Kang SH, Kim MY, Eom YW, Baik SK. Mesenchymal stem cells for the treatment of Liver Disease: Present and perspectives. Gut Liver. 2020;14:306\u201315.","journal-title":"Gut Liver"},{"key":"3988_CR29","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1002\/cbin.11725","volume":"46","author":"H Sun","year":"2022","unstructured":"Sun H, Shi C, Ye Z, Yao B, Li C, Wang X, et al. The role of mesenchymal stem cells in liver injury. Cell Biol Int. 2022;46:501\u201311.","journal-title":"Cell Biol Int"},{"key":"3988_CR30","doi-asserted-by":"publisher","first-page":"111134","DOI":"10.1016\/j.intimp.2023.111134","volume":"125","author":"M Yuan","year":"2023","unstructured":"Yuan M, Yao L, Chen P, Wang Z, Liu P, Xiong Z, et al. Human umbilical cord mesenchymal stem cells inhibit liver fibrosis via the microRNA-148a-5p\/SLIT3 axis. Int Immunopharmacol. 2023;125:111134.","journal-title":"Int Immunopharmacol"},{"key":"3988_CR31","doi-asserted-by":"crossref","unstructured":"Liu H, Wang X, Deng H, Huang H, Liu Y, Zhong Z et al. Integrated Transcriptome and Metabolomics to reveal the mechanism of adipose mesenchymal stem cells in treating liver fibrosis. Int J Mol Sci. 2023;24.","DOI":"10.3390\/ijms242216086"},{"key":"3988_CR32","doi-asserted-by":"publisher","first-page":"141","DOI":"10.3350\/cmh.2015.21.2.141","volume":"21","author":"YO Jang","year":"2015","unstructured":"Jang YO, Jun BG, Baik SK, Kim MY, Kwon SO. Inhibition of hepatic stellate cells by bone marrow-derived mesenchymal stem cells in hepatic fibrosis. Clin Mol Hepatol. 2015;21:141\u20139.","journal-title":"Clin Mol Hepatol"},{"key":"3988_CR33","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1080\/13813455.2020.1752256","volume":"128","author":"M Abdelgwad","year":"2022","unstructured":"Abdelgwad M, Ewaiss M, Sabry D, Khalifa WA, Altaib ZM, Alhelf M. Comparative study on effect of mesenchymal stem cells and endothelial progenitor cells on treatment of experimental CCL4-induced liver fibrosis. Arch Physiol Biochem. 2022;128:1071\u201380.","journal-title":"Arch Physiol Biochem"},{"key":"3988_CR34","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1002\/hep.32662","volume":"77","author":"X Liu","year":"2023","unstructured":"Liu X, Tan S, Liu H, Jiang J, Wang X, Li L, et al. Hepatocyte-derived MASP1-enriched small extracellular vesicles activate HSCs to promote liver fibrosis. Hepatology (Baltimore MD). 2023;77:1181\u201397.","journal-title":"Hepatology (Baltimore MD)"},{"key":"3988_CR35","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s13287-022-02906-z","volume":"13","author":"QW Liu","year":"2022","unstructured":"Liu QW, Ying YM, Zhou JX, Zhang WJ, Liu ZX, Jia BB, et al. Human amniotic mesenchymal stem cells-derived IGFBP-3, DKK-3, and DKK-1 attenuate liver fibrosis through inhibiting hepatic stellate cell activation by blocking Wnt\/\u03b2-catenin signaling pathway in mice. Stem Cell Res Ther. 2022;13:224.","journal-title":"Stem Cell Res Ther"},{"key":"3988_CR36","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/s41575-021-00571-w","volume":"19","author":"JO Russell","year":"2022","unstructured":"Russell JO, Camargo FD. Hippo signalling in the liver: role in development, regeneration and disease. Nat Reviews Gastroenterol Hepatol. 2022;19:297\u2013312.","journal-title":"Nat Reviews Gastroenterol Hepatol"},{"key":"3988_CR37","doi-asserted-by":"publisher","first-page":"3714","DOI":"10.1016\/j.ymthe.2022.07.020","volume":"30","author":"Y Li","year":"2022","unstructured":"Li Y, Kang X, Zhou Z, Pan L, Chen H, Liang X, et al. The m(6)a methyltransferase Mettl3 deficiency attenuates hepatic stellate cell activation and liver fibrosis. Mol Therapy: J Am Soc Gene Therapy. 2022;30:3714\u201328.","journal-title":"Mol Therapy: J Am Soc Gene Therapy"},{"key":"3988_CR38","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.gendis.2019.11.003","volume":"8","author":"MR Zinatizadeh","year":"2021","unstructured":"Zinatizadeh MR, Miri SR, Zarandi PK, Chalbatani GM, Rap\u00f4so C, Mirzaei HR, et al. The Hippo Tumor Suppressor Pathway (YAP\/TAZ\/TEAD\/MST\/LATS) and EGFR-RAS-RAF-MEK in cancer metastasis. Genes Dis. 2021;8:48\u201360.","journal-title":"Genes Dis"},{"key":"3988_CR39","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1002\/hep.32105","volume":"75","author":"S Fan","year":"2022","unstructured":"Fan S, Gao Y, Qu A, Jiang Y, Li H, Xie G, et al. YAP-TEAD mediates PPAR \u03b1-induced hepatomegaly and liver regeneration in mice. Hepatology (Baltimore MD). 2022;75:74\u201388.","journal-title":"Hepatology (Baltimore MD)"},{"key":"3988_CR40","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1097\/HEP.0000000000000326","volume":"77","author":"K Du","year":"2023","unstructured":"Du K, Maeso-D\u00edaz R, Oh SH, Wang E, Chen T, Pan C, et al. Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosis. Hepatology (Baltimore MD). 2023;77:1998\u20132015.","journal-title":"Hepatology (Baltimore MD)"},{"key":"3988_CR41","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1681\/ASN.2015050499","volume":"27","author":"SG Szeto","year":"2016","unstructured":"Szeto SG, Narimatsu M, Lu M, He X, Sidiqi AM, Tolosa MF, et al. YAP\/TAZ are mechanoregulators of TGF-\u03b2-Smad signaling and renal fibrogenesis. J Am Soc Nephrology: JASN. 2016;27:3117\u201328.","journal-title":"J Am Soc Nephrology: JASN"},{"key":"3988_CR42","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.tcb.2018.03.001","volume":"28","author":"A Totaro","year":"2018","unstructured":"Totaro A, Castellan M, Di Biagio D, Piccolo S. Crosstalk between YAP\/TAZ and Notch Signaling. Trends Cell Biol. 2018;28:560\u201373.","journal-title":"Trends Cell Biol"}],"container-title":["Stem Cell Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03988-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-024-03988-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-024-03988-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,24]],"date-time":"2024-10-24T12:04:38Z","timestamp":1729771478000},"score":1,"resource":{"primary":{"URL":"https:\/\/stemcellres.biomedcentral.com\/articles\/10.1186\/s13287-024-03988-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,24]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["3988"],"URL":"https:\/\/doi.org\/10.1186\/s13287-024-03988-7","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,24]]},"assertion":[{"value":"30 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experiments were approved by the Sichuan Agricultural University Institutional Animal Care and Use Committee (1) Title of the approved project: Differentiation and antifibrotic effect ability of mesenchymal stem cells in liver; (2) Name of the institutional approval committee: Sichuan Experimental Animal Management Committee; (3) Approval number: SYXK 2019\u2009\u2212\u2009187; (4) Date of approval: 29 January 2019.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"378"}}